UC Davis CTSC supported cellular therapy study improves Duchenne muscular dystrophy

Image Credit
UC Davis Health Public Affairs and Marketing
Dr. Craig McDonald examing a kid with Duchenne muscular distrophy

A clinical trial at UC Davis Health and six other sites showed that a cellular therapy offers promise for patients with late-stage Duchenne muscular dystrophy (DMD), a rare genetic disorder causing muscle loss and physical impairments in young people.

CTSA Program In Action Goals
Goal 4: Innovate Processes to Increase the Quality and Efficiency of Translational Research, Particularly of Multisite Trials